+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cerebrospinal fluid norepinephrine and free -aminobutyric acid in amyotrophic lateral sclerosis



Cerebrospinal fluid norepinephrine and free -aminobutyric acid in amyotrophic lateral sclerosis



Brain Research Bulletin 5: 765-768




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 061572207

Download citation: RISBibTeXText

DOI: 10.1016/0361-9230(80)90126-4


Related references

Free amino acid pattern of cerebrospinal fluid in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica 77(1): 50-53, 1988

Norepinephrine and gamma-aminobutyric acid in amyotrophic lateral sclerosis. Neurology 30(1): 98-101, 1980

Amino acid concentration in the cerebrospinal fluid in amyotrophic lateral sclerosis. Medical Science Research 21(15): 561-562, 1993

Cerebrospinal fluid from amyotrophic lateral sclerosis has no effect on intracellular free calcium in cultured cortical neurons. Molecular and Chemical Neuropathology 29(2-3): 141-152, 1996

Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid. Annals of Neurology 28(1): 12-17, 1990

Free insulin-like growth factor (IGF)-1 and IGF-binding proteins-2 and -3 in serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients. European Journal of Neurology 17(3): 398-404, 2010

Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease. Neurochemistry International 45(1): 57-62, 2004

Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic Acid in patients with amyotrophic lateral sclerosis. Clinical Neuropharmacology 33(1): 17-21, 2010

Free amino acid gas chromatographic patterns in cerebro spinal fluid of patients with amyotrophic lateral sclerosis and multiple sclerosis. International Congress Series : 201, 1969

Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis. Journal of Proteome Research 14(11): 4486-4501, 2016

Cerebrospinal fluid filtration in amyotrophic lateral sclerosis. European Journal of Neurology 6(5): 597-600, Sept, 1999

Cerebrospinal fluid cytotoxicity in lateral amyotrophic sclerosis. Neurologia 25(6): 364-373, 2011

Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis. Journal of Neurology 231(2): 75-78, 1984

Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis. Neuroscience Letters 416(3): 257-260, 2007

Cerebrospinal fluid proteins in the course of amyotrophic lateral sclerosis. Revue Neurologique 125(5): 393-400, 1971